{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:37:41Z","timestamp":1762673861953},"reference-count":77,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T00:00:00Z","timestamp":1323129600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0028638","type":"journal-article","created":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T22:07:24Z","timestamp":1323209244000},"page":"e28638","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Upregulation of the Cell-Cycle Regulator RGC-32 in Epstein-Barr Virus-Immortalized Cells"],"prefix":"10.1371","volume":"6","author":[{"given":"Sandra N.","family":"Schlick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. David","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Gunnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen M.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarika","family":"Khasnis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aloys","family":"Schepers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle J.","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,12,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ijc.2910030619","article-title":"Transformation of foetal human leukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus.","volume":"3","author":"JH Pope","year":"1968","journal-title":"Int J Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on.","volume":"4","author":"LS Young","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1073\/pnas.2237267100","article-title":"Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.","volume":"101","author":"D Hochberg","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"12250","DOI":"10.1073\/pnas.200366597","article-title":"Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors.","volume":"97","author":"GJ Babcock","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1038\/sj.onc.1206838","article-title":"Epstein-Barr virus can inhibit genotoxin-induced G1 arrest downstream of p53 by preventing the inactivation of CDK2.","volume":"22","author":"J O'Nions","year":"2003","journal-title":"Oncogene"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"12408","DOI":"10.1128\/JVI.01363-06","article-title":"Epstein-Barr virus selectively deregulates DNA damage responses in normal B cells but has no detectable effect on regulation of the tumor suppressor p53.","volume":"80","author":"J O'Nions","year":"2006","journal-title":"J Virol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0014-5793(98)01391-X","article-title":"Cell cycle arrest following exposure of EBV-immortalised B-cells to gamma irradiation correlates with inhibition of cdk2 activity.","volume":"439","author":"EJ Cannell","year":"1998","journal-title":"FEBS Lett"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1128\/MCB.20.4.1344-1360.2000","article-title":"Epstein-Barr virus suppresses a G(2)\/M checkpoint activated by genotoxins.","volume":"20","author":"M Wade","year":"2000","journal-title":"Mol Cell Biol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/sj.onc.1207253","article-title":"The EBNA-3 gene family proteins disrupt the G2\/M checkpoint.","volume":"23","author":"KG Krauer","year":"2004","journal-title":"Oncogene"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1128\/JVI.01096-06","article-title":"Epstein-barr virus-induced resistance to drugs that activate the mitotic spindle assembly checkpoint in Burkitt's lymphoma cells.","volume":"81","author":"M Leao","year":"2007","journal-title":"J Virol"},{"key":"ref11","first-page":"2541","article-title":"Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7.","volume":"13","author":"GA Parker","year":"1996","journal-title":"Oncogene"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/sj.onc.1203327","article-title":"Epstein-Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis.","volume":"19","author":"GA Parker","year":"2000","journal-title":"Oncogene"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"19500","DOI":"10.1073\/pnas.0604919104","article-title":"Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells.","volume":"103","author":"S Maruo","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1073\/pnas.1019599108","article-title":"Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression.","volume":"108","author":"S Maruo","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.onc.1210668","article-title":"Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma.","volume":"27","author":"E Anderton","year":"2008","journal-title":"Oncogene"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e1000951","DOI":"10.1371\/journal.ppat.1000951","article-title":"Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP.","volume":"6","author":"L Skalska","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"12857","DOI":"10.1128\/JVI.78.23.12857-12867.2004","article-title":"A cyclin-binding motif within the amino-terminal homology domain of EBNA3C binds cyclin A and modulates cyclin A-dependent kinase activity in Epstein-Barr virus-infected cells.","volume":"78","author":"JS Knight","year":"2004","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1128\/JVI.78.4.1981-1991.2004","article-title":"Epstein-Barr virus nuclear antigen 3C regulates cyclin A\/p27 complexes and enhances cyclin A-dependent kinase activity.","volume":"78","author":"JS Knight","year":"2004","journal-title":"J Virol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1128\/MCB.25.5.1749-1763.2005","article-title":"SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen.","volume":"25","author":"JS Knight","year":"2005","journal-title":"Mol Cell Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"18562","DOI":"10.1073\/pnas.0503886102","article-title":"Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase.","volume":"102","author":"JS Knight","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1128\/JVI.00053-07","article-title":"The ATM\/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2\/M cell cycle block.","volume":"81","author":"T Choudhuri","year":"2007","journal-title":"J Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1128\/JVI.02500-07","article-title":"Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein.","volume":"82","author":"BG Bajaj","year":"2008","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.virol.2009.03.027","article-title":"Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities.","volume":"388","author":"F Yi","year":"2009","journal-title":"Virology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1128\/JVI.02408-08","article-title":"Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.","volume":"83","author":"A Saha","year":"2009","journal-title":"J Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e1001275","DOI":"10.1371\/journal.ppat.1001275","article-title":"Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.","volume":"7","author":"A Saha","year":"2011","journal-title":"PLoS Pathog"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1128\/JVI.02279-10","article-title":"EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5.","volume":"85","author":"A Saha","year":"2011","journal-title":"J Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"26977","DOI":"10.1074\/jbc.273.41.26977","article-title":"Molecular cloning and characterization of RGC-32, a novel gene induced by complement activation in oligodendrocytes.","volume":"273","author":"TC Badea","year":"1998","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1074\/jbc.M109354200","article-title":"RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase.","volume":"277","author":"T Badea","year":"2002","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.yexmp.2008.12.005","article-title":"Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells.","volume":"86","author":"M Fosbrink","year":"2009","journal-title":"Exp Mol Pathol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/sj.onc.1210148","article-title":"RGC32, a novel p53-inducible gene, is located on centrosomes during mitosis and results in G2\/M arrest.","volume":"26","author":"K Saigusa","year":"2007","journal-title":"Oncogene"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","article-title":"A multigenic program mediating breast cancer metastasis to bone.","volume":"3","author":"Y Kang","year":"2003","journal-title":"Cancer Cell"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"8065","DOI":"10.1038\/sj.onc.1207959","article-title":"Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways.","volume":"23","author":"H Donninger","year":"2004","journal-title":"Oncogene"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.yexmp.2004.11.001","article-title":"Overexpression of RGC-32 in colon cancer and other tumors.","volume":"78","author":"M Fosbrink","year":"2005","journal-title":"Exp Mol Pathol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.yexmp.2009.10.010","article-title":"Epigenetic modifications induced by RGC-32 in colon cancer.","volume":"88","author":"SI Vlaicu","year":"2010","journal-title":"Exp Mol Pathol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1200\/JCO.2005.02.9405","article-title":"Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas.","volume":"24","author":"M Bredel","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/blood-2005-11-013458","article-title":"The molecular classification of multiple myeloma.","volume":"108","author":"F Zhan","year":"2006","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/cncr.25451","article-title":"Promoter methylation of the RGC32 gene in nonsmall cell lung cancer.","volume":"117","author":"DS Kim","year":"2011","journal-title":"Cancer"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00005-008-0016-3","article-title":"Role of response gene to complement 32 in diseases.","volume":"56","author":"SI Vlaicu","year":"2008","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/349612a0","article-title":"Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis.","volume":"349","author":"CD Gregory","year":"1991","journal-title":"Nature"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1128\/JVI.76.10.4919-4927.2002","article-title":"Expression of transcription factor AML-2 (RUNX3, CBF(alpha)-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype.","volume":"76","author":"LC Spender","year":"2002","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1038\/sj.onc.1208404","article-title":"Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells.","volume":"24","author":"LC Spender","year":"2005","journal-title":"Oncogene"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1210\/en.2007-1129","article-title":"Response gene to complement 32 expression is induced by the luteinizing hormone (LH) surge and regulated by LH-induced mediators in the rodent ovary.","volume":"149","author":"ES Park","year":"2008","journal-title":"Endocrinology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1210\/me.2005-0512","article-title":"Luteinizing hormone-induced RUNX1 regulates the expression of genes in granulosa cells of rat periovulatory follicles.","volume":"20","author":"M Jo","year":"2006","journal-title":"Mol Endocrinol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1038\/onc.2008.195","article-title":"Gene array analysis reveals a common Runx transcriptional programme controlling cell adhesion and survival.","volume":"27","author":"S Wotton","year":"2008","journal-title":"Oncogene"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"e1000506","DOI":"10.1371\/journal.ppat.1000506","article-title":"Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes.","volume":"5","author":"ML Hertle","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"9761","DOI":"10.1128\/JVI.00665-06","article-title":"Cellular target genes of Epstein-Barr virus nuclear antigen 2.","volume":"80","author":"S Maier","year":"2006","journal-title":"J Virol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e13979","DOI":"10.1371\/journal.pone.0013979","article-title":"Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification.","volume":"5","author":"RE White","year":"2010","journal-title":"PLoS One"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1471-2407-6-154","article-title":"TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells.","volume":"6","author":"SW Oram","year":"2006","journal-title":"BMC Cancer"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000074345","article-title":"Expression pattern of a gonadoblastoma candidate gene suggests a role of the Y chromosome in prostate cancer.","volume":"101","author":"YF Lau","year":"2003","journal-title":"Cytogenet Genome Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1086\/302353","article-title":"Gonadoblastoma, testicular and prostate cancers, and the TSPY gene.","volume":"64","author":"YF Lau","year":"1999","journal-title":"Am J Hum Genet"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/carcin\/bgi152","article-title":"Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies.","volume":"26","author":"WM Gallagher","year":"2005","journal-title":"Carcinogenesis"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/sj.bjc.6602716","article-title":"TSPY is a cancer testis antigen expressed in human hepatocellular carcinoma.","volume":"93","author":"YH Yin","year":"2005","journal-title":"Br J Cancer"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1101\/gad.13.16.2177","article-title":"A novel p34(cdc2)-binding and activating protein that is necessary and sufficient to trigger G(2)\/M progression in Xenopus oocytes.","volume":"13","author":"I Ferby","year":"1999","journal-title":"Genes Dev"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/emboj\/18.7.1869","article-title":"Speedy: a novel cell cycle regulator of the G2\/M transition.","volume":"18","author":"JL Lenormand","year":"1999","journal-title":"Embo J"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1083\/jcb.200109045","article-title":"Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2.","volume":"157","author":"LA Porter","year":"2002","journal-title":"J Cell Biol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.4161\/cc.7.19.6736","article-title":"Speedy\/Ringo C regulates S and G2 phase progression in human cells.","volume":"7","author":"A Cheng","year":"2008","journal-title":"Cell Cycle"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.4161\/cc.6.10.4252","article-title":"Speedy\/RINGO regulation of CDKs in cell cycle, checkpoint activation and apoptosis.","volume":"6","author":"RF Gastwirt","year":"2007","journal-title":"Cell Cycle"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10555-006-9006-2","article-title":"Transforming growth factor-beta in cancer and metastasis.","volume":"25","author":"SB Jakowlew","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nrc1607","article-title":"The RUNX genes: gain or loss of function in cancer.","volume":"5","author":"K Blyth","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1002\/ajmg.a.33021","article-title":"Perspectives on RUNX genes: an update.","volume":"149A","author":"MM Cohen Jr","year":"2009","journal-title":"Am J Med Genet A"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.1128\/JVI.00216-09","article-title":"Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferation.","volume":"83","author":"G Brady","year":"2009","journal-title":"J Virol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.virol.2008.09.018","article-title":"Epstein-Barr virus growth\/latency III program alters cellular microRNA expression.","volume":"382","author":"JE Cameron","year":"2008","journal-title":"Virology"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ygeno.2004.10.003","article-title":"Identification and characterization of RNA sequences to which human PUMILIO-2 (PUM2) and deleted in Azoospermia-like (DAZL) bind.","volume":"85","author":"M Fox","year":"2005","journal-title":"Genomics"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cell.2010.03.009","article-title":"Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP.","volume":"141","author":"M Hafner","year":"2010","journal-title":"Cell"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"e3164","DOI":"10.1371\/journal.pone.0003164","article-title":"Comparative analysis of mRNA targets for human PUF-family proteins suggests extensive interaction with the miRNA regulatory system.","volume":"3","author":"A Galgano","year":"2008","journal-title":"PLoS One"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1128\/JVI.64.5.2309-2318.1990","article-title":"Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.","volume":"64","author":"F Wang","year":"1990","journal-title":"J Virol"},{"key":"ref67","first-page":"276","article-title":"Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.","volume":"22","author":"J Menezes","year":"1975","journal-title":"Biomedicine"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ijc.2910190105","article-title":"Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75).","volume":"19","author":"H Ben-Bassat","year":"1977","journal-title":"Int J Cancer"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"9431","DOI":"10.1128\/JVI.78.17.9431-9445.2004","article-title":"Biophysical and mutational analysis of the putative bZIP domain of Epstein-Barr virus EBNA 3C.","volume":"78","author":"MJ West","year":"2004","journal-title":"J Virol"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1128\/JVI.36.2.506-518.1980","article-title":"Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line.","volume":"36","author":"W King","year":"1980","journal-title":"J Virol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1002\/j.1460-2075.1994.tb06634.x","article-title":"EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus.","volume":"13","author":"AJ Sinclair","year":"1994","journal-title":"Embo J"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1242\/jcs.00708","article-title":"Complex protein-DNA dynamics at the latent origin of DNA replication of Epstein-Barr virus.","volume":"116","author":"M Ritzi","year":"2003","journal-title":"J Cell Sci"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1128\/MCB.22.17.6183-6198.2002","article-title":"Gamma interferon and cadmium treatments modulate eukaryotic initiation factor 4E-dependent mRNA transport of cyclin D1 in a PML-dependent manner.","volume":"22","author":"I Topisirovic","year":"2002","journal-title":"Mol Cell Biol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"8524","DOI":"10.1128\/JVI.75.18.8524-8537.2001","article-title":"Activation of human immunodeficiency virus transcription in T cells revisited: NF-kappaB p65 stimulates transcriptional elongation.","volume":"75","author":"MJ West","year":"2001","journal-title":"J Virol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/sj.onc.1209205","article-title":"EBV EBNA 2 stimulates CDK9-dependent transcription and RNA polymerase II phosphorylation on serine 5.","volume":"25","author":"SJ Bark-Jones","year":"2006","journal-title":"Oncogene"},{"key":"ref76","first-page":"2515","article-title":"Translational upregulation of the c-myc oncogene in Bloom's syndrome cell lines.","volume":"11","author":"MJ West","year":"1995","journal-title":"Oncogene"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1017\/S1355838298981080","article-title":"Cap-independent polysomal association of natural mRNAs encoding c-myc, BiP, and eIF4G conferred by internal ribosome entry sites.","volume":"4","author":"G Johannes","year":"1998","journal-title":"Rna"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0028638","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T10:15:14Z","timestamp":1593339314000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0028638"}},"subtitle":[],"editor":[{"given":"Micah","family":"Luftig","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,12,6]]},"references-count":77,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,12,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0028638","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,6]]}}}